Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Optimalisatie van cardiovasculaire preventie nodig bij PsA-patiënten
mei 2018 | Arthritis psoriatica, Atherosclerose, RA